Psychiatry SC072: Schizophrenia And Related Psychoses Flashcards

1
Q

Psychosis vs Psychotic disorder vs Schizophrenia

A

Psychosis: “Out of reality”
Neurosis: Depression, Anxiety, Insomnia, etc. (Milder)

Psychosis:
- Broad umbrella term
- **Syndrome (a group of symptoms without established cause) characterised by hallmarks of symptoms:
1. **
Delusion
2. **Hallucination
3. **
Disorganisation (Thinking / Behaviour)
4. ***Lack of insight

Classification of Psychosis:
1. **Organic (identifiable physical conditions leading to psychotic symptoms e.g. drug-induced, dementia, thyroid disease, endocrine disease, brain tumour, epilepsy, encephalitis etc.)
2. **
Psychiatric

Psychotic disorder:
- Group of conditions e.g. Schizophrenia, Delusional disorder, Brief psychotic disorder, Mood disorder with psychotic symptoms
- **Affective / **Non-affective
- Non-affective: Schizophrenia, Delusional disorder, Brief psychotic disorder

Schizophrenia:
- 1 type of Psychotic disorder

Chinese term in HK (since 2001): 思覺失調
- 思: Delusion + Disorganisation
- 覺: Hallucination
- 失調: Lost balance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

***DSM-5 diagnostic criteria of Schizophrenia

A

A. **>=2 of the following, each present for a **significant portion of time during a **1-month period (or less if successfully treated). **>=1 of these must be (1), (2), or (3):
1. **Delusions
2. **
Hallucinations
3. **Disorganized speech (e.g., frequent derailment or incoherence)
4. **
Grossly disorganized / Catatonic behavior
5. ***Negative symptoms (i.e., diminished emotional expression or avolition)

B. For a significant portion of the time since the onset of the disturbance, level of functioning in one or more major areas, such as work, interpersonal relations, or self-care, is markedly below the level achieved prior to the onset (or when the onset is in childhood or adolescence, there is failure to achieve expected level of interpersonal, academic, or occupational functioning).

C. Continuous signs of the disturbance persist for **>=6 months. This 6-month period must include **>=1 month of symptoms (or less if successfully treated) that meet Criterion A (i.e., active-phase symptoms) and may include periods of prodromal or residual symptoms. During these prodromal or residual periods, the signs of the disturbance may be manifested by only negative symptoms or by two or more symptoms listed in Criterion A present in an attenuated form (e.g., odd beliefs, unusual perceptual experiences).

D. Schizoaffective disorder and depressive or bipolar disorder with psychotic features have been ruled out because either 1) no major depressive or manic episodes have occurred concurrently with the active-phase symptoms, or 2) if mood episodes have occurred during active-phase symptoms, they have been present for a minority of the total duration of the active and residual periods of the illness.

E. The disturbance is not attributable to the physiological effects of a substance (e.g., a drug of abuse, a medication) or another medical condition.

F. If there is a history of autism spectrum disorder or a communication disorder of childhood onset, the additional diagnosis of schizophrenia is made only if prominent delusions or hallucinations, in addition to the other required symptoms of schizophrenia, are also present for >=1 month (or less if successfully treated).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

***Schizophrenia-spectrum + Other Non-affective psychoses

A
  1. Schizophrenia-spectrum
    - **Schizophrenia
    - **
    Schizoaffective disorder (concurrent schizophrenic + mood symptoms **equally prominent (fulfilling a major mood episode e.g. manic / depressive episode))
    - **
    Schizotypal personality disorder (no psychotic symptoms, very mild trait, high risk of developing schizophrenia later)
  2. Other Non-affective psychoses
    - Brief psychotic disorder / **Acute + Transient psychotic disorders (ATPD)
    —> Acute onset + Brief period + Complete remission (1-3 months, depends on criteria) (better prognosis)
    —> DSM-5: **
    >1 day, ***<1 month
    —> Polymorphic features (~cycloid psychosis): rapidly changing clinical pictures, prominent fluctuated mood state, perplexity

(- Schizophreniform disorder: **>1, **<6 months of illness)

  • **Delusional disorder
    —> **
    Systematised, likely **single-theme delusion, **non-bizarre in nature (classic definition)
    —> ***No / Non-prominent hallucination
    —> Minimal negative symptoms, reported of having better functioning
    —> Over-represented by women + adult-onset
    —> Relatively rare
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

***Subtypes of Schizophrenia + Historical background

A
  • Unitary psychosis (1861)
  • Dementia praecox (1896)
  • Schizophrenia (1911)

Kraepelian dichotomy on Psychosis:
- Dementia praecox (now known as Schizophrenia) vs Manic-depressive insanity (i.e. Bipolar disorder)
- Diagnostic classification based mainly on longitudinal outcome
- Dementia praecox: Progressive downhill course (but now recognised that some schizophrenia patients may actually improve)
—> Dementia: **Cognitive decline
—> Praecox: **
Precocious
—> Kraepilian: Schizophrenia is NOT just psychotic symptoms but also early decline in cognitive function

Schizophrenia:
- Greek: Splitting of mind / psychic functions
- A group of schizophrenia with fundamental symptoms: Loosening of association, Affect flattening, Autism, Ambivalence
- 4 classic subtypes:
1. **Paranoid schizophrenia
- Prominent **
positive symptoms (not just paranoid delusion)

  1. **Hebephrenic (Disorganised)
    - Younger age of onset
    - Prominent **
    thought disorder / ***incongruous affect
    - Poor prognosis
  2. ***Catatonic
    - Constellation of specific motor signs (e.g. posturing, waxy flexibility, mutism)
  3. **Simple
    - Lack of positive symptoms (No psychotic symptoms at all)
    - **
    Prominent negative symptoms (Cognitive impairment)
    - Gradual functional decline
    - Worst prognosis
    - Rare now

—> Subtype can change over patient’s disease course
—> Subtype classification NO longer included in DSM-5 (∵ not accurate in predicting prognosis)
—> Catatonia is ***NOT specific to schizophrenia and now a specifier in DSM-5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

***Symptomatology of Schizophrenia

A

Symptom dimensions in Schizophrenia (+ related psychoses):
1. **Positive symptoms
- Delusions
- Hallucinations
2. **
Negative symptoms
- Affect flattening
- Alogia
- Anhedonia
- Avolition
- Asociality
3. Disorganisation (Formal thought disorder)
- Direction
- Tempo
- Amount
- Continuity
- Form
- Others
4. **Affective / Mood symptoms (Depression / Mania)
5. **
Motor signs (Catatonia)
6. Cognitive impairment

Positive symptoms:
Most common:
- **Delusion of reference
- **
Delusion of persecution
- ***Auditory verbal hallucination (AVH)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Positive symptoms

A

Schneiderian ***First Rank Symptoms (FRS): (i.e. first rank of importance, specific to schizophrenia —> facilitate diagnosis)
- now know that FRS are NOT specific to schizophrenia + minimal prognostic predictive value
- but still widely applied + emphasised in current classifications

Delusion:
1. **Thought alienation (thought insertion, withdrawal, broadcasting)
2. **
Delusion of Passivity / Control (i.e. feelings, actions, impulse etc. experienced as made / influenced by external agents)
3. ***Delusional perception (a true perception in which a patient attributes a false meaning)

Hallucination:
4. **3rd person AVH with voices conversing with each other
5. 3rd person AVH in the form of **
running commentary (hallucination of voice continuously commenting on one’s actions)
6. ***Thought echo (AVH with voice repeating one’s own thoughts aloud)
7. Somatic hallucination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

***Delusion

A
  • **A firmly held belief (unshakeable) on **inadequate ground
  • ***Not subject to reason / contradictory evidence
  • ***Not explained by a person’s usual cultural and religious background
  • Important issue: Collect collateral information from informant for uncertain situation

Possible theme:
1. **Delusion of reference
2. **
Delusion of persecution
3. **Grandiose delusion
4. **
Delusion of guilt
5. **Delusion of poverty
6. Delusion of infidelity / jealousy
7. Delusion of control / passivity
8. **
Erotomania (de Clérambault’s Syndrome)
9. Nihilistic delusion (Cotard’s syndrome, delusional belief of being dead)
10. Religious delusion
11. Somatic delusion (Hypochondriacal)
12. **
Misidentification (
Capgras syndrome (belief that a close person has been replaced by an identical imposter i.e. faked), **Fregoli syndrome (an unfamiliar person as a familiar person))
13. **Thought alienation
14. **
Hypochondriacal delusion
15. Dysmorphophobic delusion
16. Shared delusions (Folie a deux)

Characteristics of delusion:
1. Content?
2. How did the belief form?
3. Can it be explained by the person’s educational / cultural / religious background?
4. **Any other possible alternative explanation? (會唔會巧合呀?)
5. Extent of conviction?
6. **
Response to contrary evidence?
7. **Mood-congruent? (Mood disorder with Psychotic symptoms are usually congruent vs Schizoaffective)
8. Bizarre?
9. **
Reaction (e.g. Acting out)
10. ***Impact (Physical, Psychological, Social)

(Ryan Ho:
Classification of Delusions:
1. Primary delusions (un-understandable, not occurring with other psychiatric illness)
- Autochthonous delusion (Delusional intuition) (occur out of blue)
- Delusional perception
- Delusional atmosphere (foreboding feeling in which the patient experiences everything around him in a sinister, peculiar way i.e. 不祥的預感)
- Delusional memory (delusional interpretation of normal memory)

  1. Secondary delusions (delusion arise from other psychiatric illness e.g. schizophrenia)

vs Partial delusions:
- ***Less conviction

vs Overvalued ideas:
- Beliefs ***plausible in nature (i.e. understandable) but Overvalued (i.e. preoccupied to an unreasonable extent)
- in Anorexia nervosa, Hypochondriacal disorder

vs Obsessions:
- ***Egodystonic (i.e. patient does not believe + actively resist the idea but have compulsion)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

***Hallucination

A
  • ***Perception without stimulus
  • ***Cannot be controlled
  • Important issue: Clarify if it’s a perception without stimulus! (Other people cannot hear / feel)

Form:
1. **Auditory (most common)
2. **
Visual
3. Gustatory
4. Olfactory
5. ***Tactile / Somatic

Characteristics of Auditory hallucination:
1. External (真係無人?)
2. Elementary (
non-verbal, hissing, whistling, an extended tone, tinnitus etc.) / Complex (**verbal, voices, music)
3. **
2nd person / 3rd person
4. **Number of voices
5. **
Identity (e.g. gender, age, familiarity)
6. **Content (derogatory, command etc.)
7. **
Pattern (Frequency, Duration, Intensity, Setting **真係無人?)
8. **
Vividness (係咪清楚?)
9. **Uncontrollable
10. **
Reaction
11. ***Impact (Physical, Psychological, Social)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Negative symptoms

A
  • Symptoms where there is a **decrease / **loss in a mental ***function compared to normal functioning
  • Core feature of schizophrenia
  • ***KEY determinant of functional outcome
  • Unmet therapeutic need, ***NOT respond to Antipsychotic
  • Important issue: Need to rule out ***secondary causes such as antipsychotic side effect and depression
  • Multi-dimensional construct comprising 5”A”s

5“A”s:
1. ***Affect flattening
- reduced affect response (facial expression, gesture, spontaneous movement, intonation, eye contact)
- diminished non-verbal emotional expression

  1. ***Alogia
    - poverty of speech
    - diminished verbal emotional expression
  2. ***Anhedonia
    - reduced capacity to experience pleasure
    - similar but not same as Anhedonia in depression
  3. ***Avolition
    - reduced motivation with reduced goal-directed behaviour
  4. ***Asociality
    - reduced motivation with reduced social drive with social withdrawal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Cognitive impairment

A
  • Core feature of schizophrenia (Dementia praecox)
  • ***KEY determinant of functional outcome (some patients may not recover!)
  • Unmet therapeutic need, NOT respond to Antipsychotic

***Generalised (NOT Isolated) cognitive impairment encompass multiple cognitive domains:
1. Sustained attention
2. Executive functions (planning, set-shifting, inhibition control)
3. Working memory
4. Verbal + Visual memory
5. Processing speed

  • In general, 1-2 SD below normal individuals
  • Healthy 1st degree relative also demonstrate deficits (although less severe) in cognition
  • Impairment in ***social cognition observed including deficits in ToM (theory of mind: ability to think about mental states, both your own and those of others), emotion recognition etc.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Epidemiology of Schizophrenia + Related psychoses

A

Epidemiology:
- Prevalence: ~2-3%
- Incidence rates vary widely across regions
- Elevated incidence among:
—> Migrants of ethnic minority (from developing countries to developed countries) (not just 1st generation but also 2nd generation)
—> Urbanicity: Individuals brought up in urban area vs those in rural areas
- One of leading disabilities worldwide
- Direct cost (hospitalisation, medication)
- Indirect cost (loss of productivity, disability allowance)
- Profound disruption in individual’s personality development, social relationship, scholastic, vocational trajectories
- Potentially chronic, remitting-relapse course with significant functional impairment

Schizophrenia:
- **Lifetime risk: ~1%
- Median incidence rate: 15.2 / 100,000 per year
- Onset: Late adolescence + Early adulthood
- **
M:F = 1.4:1
- **M: **Earlier age of onset of psychosis
- F: Have **second peak of onset ~40-50 (~age of menopause) (*Estrogen theory: Estrogen block Dopamine receptor —> Protective effect)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Suicide, Mortality in Schizophrenia

A

**Suicide:
- Single largest cause of premature death in schizophrenia
- **
5.6% lifetime risk
- **12x higher than normal population
- Highest risk in **
early stage of psychotic disorder
- Rate is highest in first year after FEP
- Depressed mood, one of strongest predictor of suicide, frequently observed in ***early stage of illness

Mortality:
- Excess mortality in schizophrenia patients
- Schizophrenia reduces an affected individual’s lifespan by on average **10-15 years
- Elevated both in **
suicide + **natural deaths
- Possible reasons for elevated rate of natural deaths:
1. **
Lifestyle (sedentary lifestyle, lack of exercise, poor nutrition)
2. **Cigarette smoking, substance or alcohol abuse
3. **
Metabolic syndrome (obesity, DM, hyperlipidaemia etc.)
4. ***2nd generation antipsychotic (contribute to metabolic syndrome)
5. ?Inherent disease process involving accelerated aging and medical morbidity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Development + Course of Schizophrenia

A

Premorbid phase (Childhood)
—> Prodrome (At risk mental state (ARMS) / **Clinical high-risk (CHR)) (few months-years) (Adolescence / Early adulthood)
—> **
First episode of psychosis (FEP) (i.e. onset of psychosis) / No transition to psychosis (Adolescence / Early adulthood)
—> Longitudinal course of illness (very heterogeneous: some can fully recover, some relapse-remit (likely ∵ non-adherence), some resistant to treatment)
—> Residual deficits / Fully recovered

Prodrome:
- Low grade / Attenuated positive symptoms but not above threshold for formal diagnostic category
- e.g. some decline in functioning, poorer social function, mild cognitive impairment
- May not be easily noticed by patient / people around

FEP:
- Good treatment response (>70%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Causes of Schizophrenia

A

Gene x Environment interactions
1. Genetic
- **High degree of heritability (estimated as 80% contributed by genetic cause)
—> **
First-degree relatives: 10-15%
—> **Monozygotic twin: 50%
- **
Polygenic (multiple genes with small effects contributed by each gene)
- Many identified candidate genes are related to dopamine, glutamate, synaptic functions, immune mechanisms
- Rare copy number variants (CNV) with larger effect (e.g. Chromosome 22q11.2 deletion syndrome (DiGeorge Syndrome / Velo-cardio-facial syndrome (VCFS)) (20-30x risk of schizophrenia)

  1. Environmental
    Prenatal + Perinatal risk factors (Distal factors) (Non-specific: also involved in other neurodevelopmental diseases e.g. Autism, Bipolar)
    - **Obstetric complications (higher risk of neurodevelopmental diseases)
    - **
    Winter birth, **Maternal infections (e.g. influenza, toxoplasmosis) (trigger immunity —> neuroinflammation in fetus)
    - **
    Advanced paternal age at conception (de novo mutation / epigenetic)

Proximal social risk factors
- **Substance abuse (cannabis, amphetamine, ketamine)
- **
Migration (ethnic minority) (social defeat hypothesis / stress dopamine sensitization)
- ***Urbanicity (urban upbringing)

**Neurodevelopmental hypothesis:
- Low IQ / mental retardation associated with higher risk of schizophrenia
- Poor premorbid adjustment
- Motor function deficits occur before onset of illness
- Neurological soft signs
- Cognitive deficits emerge in **
prodromal period

***Stress-vulnerability model for psychosis development
- Stress: Social / Environmental factors
- Vulnerability: Genetic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Neurobiological abnormalities in Schizophrenia

A
  1. Biochemical
    ***Dopamine hypothesis:
    - ↑ Pre-synaptic dopamine synthesis in Striatum —> Hyperdopaminergic transmission —> Psychosis

Dopamine pathways:
1. Mesolimbic pathway (positive symptoms)
2. Mesocortical pathway (negative + cognitive symptoms)
3. Nigrostriatal pathway (parkinsonism / EPS)
4. Tuberoinfundibular pathway (hyperprolactinaemia)

Other neurotransmitters involved:
- ***Glutamate (NMDA hypofunction) —> Excess glutamate neurotransmission —> Neurotoxicity —> may lead to hyperdopaminergia
- GABA

Neuropathological findings:
- Absence of gliosis + lack of evidence of neuronal loss + reduction in synapse-rich neuropil (—> against neurodegeneration hypothesis)

  1. Structural / Neuroanatomical abnormalities (by sMRI)
    - ↓ Whole brain volume / ***Gray matter (GM) volume (esp. temporal lobe (hippocampus, amygdala, superior temporal gyri (STG)), prefrontal cortex, thalamus, anterior cingulate)
    - ↑ Ventricular volume
    - ↓ Cortical thickness (cortical thinning)
    - ↓ Cortical surface area
  2. Structural + Functional connectivity alterations
    - Altered integrity of ***white matter tracts (via DTI)
    - Altered resting-state functional connectivity (via fMRI)
  • Evidence indicates a ***progressive structural brain changes (volume reduction) across the course of illness, at least in a subgroup of patients
  • Alterations in neurophysiological measures + in-vivo brain functions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Treatment of Schizophrenia

A
  1. Pharmacological treatment
    - Antipsychotic
    —> Effective in **positive symptoms
    —> **
    >80% of patients respond to antipsychotic in FEP
    —> Mechanism: D2 receptor antagonist in Striatum
    —> Excessive D2 blockade (>70-80% of striatal D2 receptors) —> Motor SE
    —> SE: **EPS, **Metabolic, **QT prolongation, **Neuroleptic malignant syndrome

High risk of relapse:
- Major risk factor: non-adherence to medication
- ***>=1-2 year maintenance antipsychotic following positive symptom remission is recommended for FEP

**Treatment-resistant schizophrenia:
- Persistent, prominent positive symptoms despite **
>=2 trials of different types of antipsychotic with adequate dose + duration (6-8 weeks)
- Indication for ***Clozapine initiation

  1. Non-pharmacological treatments
    - CBT
    —> Residual positive psychotic symptoms (e.g. residual AH)
    —> Comorbid depressive / anxiety symptoms
    - Treatment compliance therapy
    - Cognitive remediation
    - Occupational rehabilitation / vocational support + training / social skills training
    - Community case-management approach
    - Family intervention (expressed emotions (EE), caregiver stress + burden, psychoeducation, support)
    - Electroconvulsive therapy (ECT) (for catatonia / treatment-resistant schizophrenia)
17
Q

Typical antipsychotics

A
  • Efficacy comparable to Atypical antipsychotic
  • Prone to Extrapyramidal SE (Dose‐related + More likely in high‐potency drugs)
    1. ***Dystonia (扭麻花)
  • oculogyric crisis, torticollis
  • hyperkinetic movement disorder, intermittent, uncoordinated involuntary contractions of muscle of face, tongue, neck, trunk, extremities
  • painful
  • treatment: **Anticholinergic (balance out anti-dopamine effect), **BDZ
  1. **Akathisia
    - motor restlessness, inability to stay still
    - treatment: **
    Beta-blocker, ***BDZ
  2. **Pseudo‐parkinsonism
    - rigidity, tremor
    - cognitive impairment
    - treatment: **
    Anticholinergic, ***Beta-blocker
  3. **Tardive dyskinesia (tardive: delayed onset)
    - repetitive movement of Orofacial structure: tongue protrusion, lip smacking, involuntary repetitive body movements
    - painless
    - can be irreversible
    - treatment: **
    Stop, **Decrease dosage, **Change to atypical, ***Clozapine

Oral:
1. Chlorpromazine
2. Haloperidol
3. Trifluoperazine
4. Perphenazine
5. Sulpiride

Depot (injection once in 3‐5 weeks):
1. Fluphenazine depot
2. Haloperidol decanoate depot
3. Flupentixol depot
4. Zuclopenthixol depot

18
Q

Atypical antipsychotics

A
  • Efficacy comparable to Typical antipsychotic
  • Less prone to cause Extrapyramidal SE
  • More metabolic side effects
    —> **Obesity
    —> **
    Hyperlipidaemia
    —> **Impaired glucose level
    —> **
    Hyperprolactinaemia
    —> Need ***regular metabolic screening

Oral:
1. Risperidone (more EPS SE + not well tolerated by PD patients, good for negative symptoms + cognition, well tolerated by elderly on low dose)
2. Olanzapine (OD dose, low EPS SE, good for negative symptoms + cognition, **
significant weight gain, NIDDM)
3. Quetiapine (
highest serotonin/dopamine binding ratios —> least EPS SE + no effect on prolactin; somnolence, dry mouth, weight gain)
4. Amisulpride (minimal EPS + reduce negative symptoms, *increase prolactin level with associated endocrine effects)
5. Ziprasidone (parenteral, favourable SE: no weight gain + no prolactin elevation, *prolong QTc (change drug))
6. Aripiprazole (
*partial agonist at D2 / D3 + 5HT1A receptor + antagonist activity of 5HT2A)
7. Sertindole (
prolong QTc, **lowest potential for EPS other than clozapine)
8. **
Clozapine (Treatment‐resistant schizophrenia)

Depot (must have injection once every 2 weeks):
1. Risperidone
2. Paliperidone
3. Olanzapine
4. Aripiprazole

19
Q

Clozapine

A
  • Failed 2 antipsychotic of >=1 **Atypical (adequate duration (*6-8 weeks) and dosage)
  • Adjust dose slowly (12.5 mg/week) —> stop ***>2 days —> titrate from 0 again
  • CBC + D/C monitoring
    —> once **per week for **18 weeks
    —> once every ***4 weeks

SE:
- Sedation
- Dizziness
- Postural hypotension
- **Hypersalivation (M4 agonist + α2 blocker)
- Constipation
- Tachycardia
- Hyper / Hypotension
- **
Fever
- ***Nocturnal enuresis

Severe + Life threatening SE:
- **Seizures (highest risk in high dose / first time, **prophylactic anticonvulsant)
- **Liver failure
- Pancreatitis
- **
Intestinal obstruction
- Pericardial effusion / PE / Myocarditis / **Cardiomyopathy
- **
Agranulocytosis (1-3%, peak between 4-18 weeks) —> CBC + D/C once per week for 18 weeks —> once every 4 weeks

20
Q

Prognosis of Schizophrenia

A

Poor prognostic factors:
- **poor premorbid adjustment
- **
early-onset / young age of onset
- **insidious onset of psychosis
- **
male
- **hebephrenic subtype
- **
prominent negative symptoms
- severe cognitive impairment
- prolonged duration of untreated psychosis (DUP)
- **comorbid substance abuse
- **
high expressed emotions (EE) of caregivers
- poor initial treatment response to antipsychotic

21
Q

Early intervention paradigm

A

Rationale:
1. Early detection: shorten treatment delay (DUP)
2. Phase-specific intervention: optimal treatment in ***critical period (first 3-5 years after illness onset)

  • Both overseas + local research consistently demonstrated effectiveness of EI over standard care on improving clinical + functional outcomes of FEP
  • HK: EASY program (Early Assessment Service for Young people with psychosis)
    —> EASY program reduced suicide + hospitalisation rates, improved functioning + symptom outcomes, lowered default rate
  • Detection + Intervention for at-risk mental state (ARMS) for psychosis (i.e., putatively prodrome for psychosis) (indicated prevention to prevent progression to full-blown psychosis)
22
Q

Suicide risk assessment (Ryan Ho)

A

Stage of suicide:
Depressed mood
—> Hopelessness
—> Pointlessness of life (I can’t see any future)
—> Passive rejection of life (I’d be better off dead)
—> Active rejection of life (I wish I were dead)
—> Passive thoughts of self-harm (I could take an overdose)
—> Active thoughts of self-harm (I will take an overdose)
—> Act

Past:
1. Demographic factors
2. Psychiatric + Medical history
3. Recent stressors

Present:
1. Current mental state
2. Suicidal attempts / intent / thoughts
- Depressed mood
- Negative thoughts (Guilt, Worthlessness, Hopelessness)
- Suicidal acts
—> Purpose (expectation of dying, perceived lethality of means)
—> Plans
—> Preparations (will, suicide note, putting affairs in order)
—> Concealment (avoid discovery, delayed being rescued)
—> Communication (not telling others, no help sought after act)
—> Attempts

Future:
1. Amenable risk factors
2. Protective factors

23
Q

***Assessment of suicidal attempts (Ryan Ho)

A
  1. Background
    - Establish suicidal attempt / ideation
    - Reason for suicide (life stressors, mood disorder, delusion, hallucination, substance abuse)
  2. Before
    - **Suicidal ideation (duration, frequency, intensity)
    - **
    Belief of intent (true intention vs attention seeking, perceived lethality)
    - ***Suicidal plan + preparation + communication
    —> Purpose (expectation of dying, perceived lethality of means)
    —> Plans
    —> Preparations (will, suicide note 遺書, putting affairs in order 身後事)
    —> Communication (not telling others)
    —> Concealment (avoid discovery, delayed being rescued)
  3. During
    - **When, Where, Who, How
    - Lethality of means
    - **
    Concealment (avoid discovery, delayed being rescued)
    - ***How patient was saved
  4. After
    - **Communication (sought help / informing others after act)
    - **
    Remorse / Reaction
    - Future attempts / plans
  5. Risk factors
    - **Previous attempts
    - Friend / Relative completing suicide
    - Psychiatric disease
    - Medical disease
    - **
    Substance abuse
    - Impulsivity
  6. ***Protective factors (有咩留戀)
    - Good social + family support
    - Good coping skills (e.g. positive problem-solving)
    - Engagement in responsibilities (e.g. children, pregnancy, pets)
24
Q

***Formal thought disorder (FTD) (Ryan Ho)

A
  1. Direction
    - Circumstantiality
    - Tangentiality
  2. Tempo
    - Retardation
    - Flight of ideas (vs Loosening of associations)
  3. Amount
    - Poverty of thought / speech (a/w Retardation)
    - Pressure of thought / speech (a/w Flight of ideas)
  4. Continuity
    - Perseveration (unnecessary repetition of thought processes beyond relevance (Palilalia, Logoclonia))
    - Thought block (sudden interruption of stream of thought)
  5. Form
    - Loosening of associations (loss of normal structure of thinking)
    —> Derailment
    —> Talking pass the point
    —> Word salad
  6. Others
    - Neologism